Zobrazeno 1 - 10
of 24
pro vyhledávání: '"H. H. D. M. Van Vliet"'
Publikováno v:
Annals of Hematology
Dear Editor, Thrombotic thrombocytopenic purpura (TTP) is a rare disease, characterised by thrombocytopenia and microangiopathic haemolytic anaemia. Under normal circumstances, unusually large multimers (UL) of von Willebrand factor (VWF) are release
Autor:
J. J. Michiels, H. H. D. M. Van Vliet, F.J. Zijlstra, F. J. Prins, D. van de Moesdijk, U. Budde, P. J. J. Van Genderen, R. Van Strik
Publikováno v:
Annals of Hematology, 215-220. Springer-Verlag
ISSUE=75;STARTPAGE=215;ENDPAGE=220;ISSN=0939-5555;TITLE=Annals of Hematology
ISSUE=75;STARTPAGE=215;ENDPAGE=220;ISSN=0939-5555;TITLE=Annals of Hematology
Patients with essential thrombocythemia (ET), who frequently have bleeding complications, may manifest an excessive prolongation of the bleeding time (BT) after ingestion of aspirin (ASA). The reason for this excessive prolongation of the BT is unkno
Autor:
A. Hofman, H. H. D. M. Van Vliet, D.E. Grobbee, Michiel L. Bots, J.G. van der Bom, Huib A.P. Pols
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 16:864-867
Antithrombin is a potent inhibitor of thrombotic tendency. Whether atherosclerotic disease is associated with high or low antithrombin is unclear. Studies of the relation between antithrombin and presence of arterial disease have shown contrasting re
Autor:
H. H. D. M. Van Vliet, V. D. Vuzevski, P. J. J. Van Genderen, Jan Jacques Michiels, F. J. Prins, I. S. Lucas, R. Van Strik
Publikováno v:
Thrombosis and Haemostasis. 76:333-338
SummaryErythromelalgia, a characteristic aspirin-responsive microvascular thrombotic complication in essential thrombocythemia (ET), may develop despite oral anticoagulant treatment or treatment with heparin, suggesting that the generation of thrombi
Publikováno v:
The Netherlands Journal of Medicine. 46:146-152
Heparin-induced thrombocytopenia (HIT) is a severe complication of heparin therapy. Life-threatening thromboembolism (HITT) may occur in a large number of patients with HIT. In this article diagnostic problems and the clinical course of 4 typical pat
Autor:
M. B. Van't Veer, T. Vink, P. J. J. Van Genderen, H. H. D. M. Van Vliet, J. J. Sixma, Jan Jacques Michiels
Publikováno v:
Blood. 84:3378-3384
An 82-year-old man with a low-grade malignant non-Hodgkin lymphoma and an IgG3 lambda monoclonal gammopathy presented a recently acquired bleeding tendency, characterized by recurrent epistaxis, easy bruising, and episodes of melena, requiring packed
Publikováno v:
British Journal of Haematology. 115:1004-1006
Pre- and post-treatment serum thrombopoietin (TPO) concentration was measured in 35 patients with immune thrombocytopenic purpura (ITP). Mean post-treatment levels were significantly lower (P = 0·02) than pretreatment and not different for treatment
Autor:
Michiel L. Bots, D. E. Grobbee, A.M. de Bruyn, H. H. D. M. Van Vliet, P.T.V.M. de Jong, Albert Hofman, E. Briët, F.A. van de Ouweland, P.J. Breslau
Publikováno v:
Hypertension, 19, 717-720. Lippincott Williams & Wilkins
The objective of the present study was to assess the prevalence of moderate and severe stenosis of the right carotid artery in the elderly and its associations with smoking, blood pressure, serum lipid levels, and hemostatic factors. The Rotterdam El
Publikováno v:
Thrombosis and Haemostasis. 75:267-269
SummaryThe currently used activated Protein C resistance test demonstrated to be of limited diagnostic value for the detection of the mutant Factor V Leiden. Moreover, this assay is not useful for patients under anticoagulant therapy. A modification
Publikováno v:
Fibrinolysis. 8:132-134
Objective: To study the distribution of factor VII coagulant activity and its association to serum lipids in the elderly. Methods: The Rotterdam study is a single centre population based prospective cohort study among 7,983 subjects aged 55 years and